Cargando…
Cytomegalovirus-specific CD8 T cells kill B16 melanoma cells in vivo when activated by bifunctional major histocompatibility class I - antibody fusion molecules (pMHCI-IgGs).
Autores principales: | Munks, Michael, Levitsky, Victor, Hill, Ann, Knoetgen, Hendrik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4649559/ http://dx.doi.org/10.1186/2051-1426-3-S2-P237 |
Ejemplares similares
-
Activation of cytomegalovirus-specific CD8(+) T-cell response by antibody-mediated peptide-major histocompatibility class I complexes
por: Schmittnaegel, Martina, et al.
Publicado: (2015) -
High-affinity CD8 variants enhance the sensitivity of pMHCI antigen recognition via low-affinity TCRs
por: Knezevic, Lea, et al.
Publicado: (2023) -
Vaccine-induced CD8 T cells are redirected with peptide-MHC class I-IgG antibody fusion proteins to eliminate tumor cells in vivo
por: Fischer, Cornelia, et al.
Publicado: (2020) -
Production of IgGs with a human-like sialylation in CHO cells
por: Raymond, Céline, et al.
Publicado: (2015) -
IgGs drive COVID-19 myeloid hyperinflammation
por: Park, Matthew D.
Publicado: (2020)